Zhitong Finance App News, Yixintang (002727.SZ) issued an announcement to meet the needs of the company's strategic development, ensure the smooth development of the company's various businesses in Henan Province, expand the company's coverage in Henan Province, ensure the smooth implementation of the company's future industrial strategy, further increase the company's overall strength and comprehensive competitiveness, enhance the company's product acquisition and distribution capabilities, and strengthen the company's pharmaceutical sales network in Henan Province.

Henan Hongxiang Yixintang Pharmaceutical Co., Ltd. (“Henan Yixintang”), a wholly-owned subsidiary of the company, acquired a controlling interest in Henan Yixintang Kangjian Pharmaceutical Co., Ltd. (“Yixintang Health” for short) and increased its registered capital.

Among them: Henan Yixintang transferred 63% of Yixintang Kangjian's shares held by Nanyang Wanjia Kangjian Pharmaceutical Chain Co., Ltd. (“Nanyang Wanjia”) with its own capital of 23.29 million yuan. After this share transfer, Henan Yixintang held 67% of Yixintang Kangjian's shares; in Nanyang Wanjia changed and registered 63% of Yixintang Kangjian's shares under the name of Henan Yixintang Health. After Henan Yixintang achieved 67% control of Yixintang Health, Henan Yixintang and Nanjia will both follow the ownership of Nanyang Wanjia The shareholding ratio completed a capital increase of 15 million yuan for Yixintang Health.